Pharma Equity Group A/S (OCSE:PEG) Pre-Tax Income : kr-31.23 Mil (TTM As of Mar. 2024)

Pharma Equity Group A/S Pre-Tax Income Chart

Pharma Equity Group A/S Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Pre-Tax Income		Get a 7-Day Free Trial					-14.42	-32.88	5.39	-11.30	-26.84

Pharma Equity Group A/S Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial															-3.21	-5.02	-4.63	-13.80	-7.79

Competitive Comparison of Pharma Equity Group A/S's Pre-Tax Income

For the Biotechnology subindustry, Pharma Equity Group A/S's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Equity Group A/S's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Equity Group A/S's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Pharma Equity Group A/S's Pre-Tax Income falls into.

Pharma Equity Group A/S Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Pharma Equity Group A/S's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pharma Equity Group A/S's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-31.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Equity Group A/S  (OCSE:PEG) Pre-Tax Income Explanation

Pharma Equity Group A/S's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Equity Group A/S Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Pharma Equity Group A/S's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Equity Group A/S (OCSE:PEG) Business Description